Abstract:Insulin is a protein hormone secreted by pancreatic,6 cells. One of its main functions is to keep the balance of glucose inside the body by regulating the absorption and metabolism of glucose in the periphery tissue, as well as the production and storage of hepatic glycogen. The insulin receptor is a transmembrane glycoprotein in which two a subunits with a molecular weight of 135 kD and two beta subunits with a molecular weight of 95 kD are joined by a disulfide bond to form a beta-alpha-alpha-beta structure. The extracellular a subunit, especially, its three domains near the N-terminal are partially responsible for signal transduction or ligand-binding, as indicated by the experiments. The extracellular a subunits are involved in binding the ligands. The experimental results indicate that the three domains of the N-terminal of the a subunits are the main determinative parts of the insulin receptor to bind the insulin or mimetic peptide. We employed the extracellular domain(PDBID: 11GR) of the insulin-like growth factor-1 receptor(IGF-1R) as the template to simulate and optimize the spatial structures of the three domains in the extracellular domain of the insulin receptor, which includes 468 residues. The work was accomplished by making use of the homology program in the Insight U package on an Origin3800 server. The docking calculations of the insulin receptor obtained by homology with hexapeptides were carried out by means of the program Affinity. The analysis indicated that there were hydrogen bonding, and electrostatic and hydrophobic effects in the docking complex of the insulin receptor with hexapeptides. Moreover, we described the spatial orientation of a mimetic peptide with agonist activity in the docking complex. We obtained a rough model of binding of DLAPSQ or STIVYS with the insulin receptor, which provides the powerful theoretical support for designing the minimal insulin mimetic peptide with agonist activity, making it possible to develop oral small molecular hypoglycemic drugs.

Identification of Insulin Mimetics from a Phage-displayed Library

Screening and Identification of A Targeting Peptide to Nglp-1r from Phage Display Peptide Library

Identifying glucagon-like peptide-1 mimetics using a novel functional reporter gene high-throughput screening assay.

Identification of Antiviral Mimetic Peptides with Interferon Α-2B-like Activity from a Random Peptide Library Using a Novel Functional Biopanning Method

Binding Mode of Insulin Receptor and Agonist Peptide

Combinatorial libraries of bipodal binders of the insulin receptor

Screening of IL-2Rα Mimotope from Phage Display Peptide Library

Selection of Small Molecules That Bind to and Activate the Insulin Receptor from a DNA-Encoded Library of Natural Products

Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library

Phage Display Screening Against A Set of Targets to Establish Peptide-Based Sugar Mimetics and Molecular Docking to Predict Binding Site

Identification of Insulin-Mimetic Plant Extracts: From an In Vitro High-Content Screen to Blood Glucose Reduction in Live Animals

Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects

Screening of Diabetes-Associated Autoantigens and Serum Antibody Profiles by Phage Display System

Identification of peptide mimetics of xenoreactive alpha-Gal antigenic epitope by phage display.

Activation of the insulin receptor by an insulin mimetic peptide

Identification of peptide mimetics of xenoreactive α-Gal antigenic epitope by phage display

Affinity Chromatography of Insulin with a Heptapeptide Ligand Selected from Phage Display Library

Supramolecular Assembly of Cp1-11 Peptide and Insulin for Rapid-Acting Formulation

Functional GLP-1R antibodies identified from a synthetic GPCR-focused library demonstrate potent blood glucose control

A Novel Peptide with Similar Pharmacology to Exenatide in Rodents As GLP-1 Receptor Agonist

Identification and Characterization of Peptide Mimics of Blood Group A Antigen